Breast Biopsy Devices Market Trends, Drivers, Growth Opportunities, Challenges, and Investment Opportunities

Breast Biopsy Market Information: By Technique Type (Biopsy Markers, Surgical Biopsy, MRI-guided Core Needle Biopsy), By Product (Biopsy Wires, Biopsy Needles), End-Users (Surgical and Diagnostic Centers)

Pune, India – June 19, 2019 —

A biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body.

Breast biopsy is a medical procedure that involves the testing of small samples of breast tissues for the detection of breast cancer.

The global Breast Biopsy Market is expected to expand in significant fashion during the forecast period of 2018 to 2023.

Data Bridge Market Research report on breast biopsy devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.

The rise in the healthcare sector globally is escalating the growth of the breast biopsy devices market.Breast biopsy devices refer to the type of medical devices that are used for breast biopsy procedures.

The biopsy includes the surgical removal of tissue or fluid for examination and determination of any possible disease.

The presence of breast cancer is checked by examining the removed tissue under microscopes.

These samples are sent to the testing laboratories where the diagnosing is done with the help of various tools and devices such as needles, tables, and wires among others.Download Sample Report @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-breast-biopsy-devices-market The major players covered in the breast biopsy devices market report are Scion Medical Technologies LLC, STERYLAB S.r.l., ARGON MEDICAL, Danaher, Cianna Medical, Benetec, Cigna, United Medical Systems Inc., Stryker, BD, Hologic Inc., Devicor Medical Products Inc., F. Hoffmann-La Roche Ltd, OncoCyte Corporation, Cook, Siemens, Medtronic, SOMATEX Medical Technologies GmbH, Trivitron Healthcare, Vigeosrl, Johnson & Johnson Services Inc., Boston Scientific Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, GENERAL ELECTRIC, Cardinal Health, and B. Braun Melsungen AG, among other domestic and global players.

Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately.

This form of biopsy is conducted with the help of minimally invasive biopsy systems due to minimal pain and disfigurement.

The global breast biopsy market is expected to expand in significant fashion during the forecast period of 2018 to 2023.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6288The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast cancer screening programs are the major drivers of the market.

In addition to these, the market growth is also restricted due to the high cost of surgical procedures and the risks associated with them.

At the same time, the emergence of technologically advanced and the usage of breast biopsy devices that are minimally invasive are expected to tap into the potential opportunities that the market holds.Market SegmentationThe global breast biopsy market segmentation is done as per technique type, product, guidance technology, and end-user.By product, the market includes biopsy tables, guidance systems, biopsy needles, biopsy wires, and others.By technique type, the market includes core needle biopsy, fine needle aspiration biopsy, wire localization, MRI-guided core needle biopsy, biopsy markers, surgical biopsy, and sentinel node biopsy.

The surgical biopsy segment is divided into excisional biopsy and incisional biopsy.By guidance technology, the market includes CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and various other image-guided breast biopsy (PET and thermography).By end-user, the market comprises of ambulatory surgical centers, hospitals, diagnostic centers, and others.Regional AnalysisThe geographical breast biopsy market segmentation covers four major regions, namely North America, Asia-Pacific, Europe, and the Middle East & Africa.North America is anticipated to hold the largest market share over the forecast period as per the market report published by MRFR.

The Europe market holds the second-largest share of the breast biopsy market due to the striking prevalence of breast cancer in the UK and Belgium.

Breast Biopsy Procedure in India.

It's a procedure in which the doctor takes a small sample of the breast tissue for testing.

There are several types of biopsy procedures to determine the specific area in the patient's breast.

The doctor examines and identifies the cells that are forming lumps, and other unusual changes.

Further, it determines if the patient needs treatment.

Contact us for more information.

Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market.

Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.The report Breast Biopsy Market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period.Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805 Market Segmentation:-Based on the product, the breast biopsy market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products.

In 2019, the biopsy needles held significant share of the market.

The major share of this segment is primarily attributed to the rising incidence of breast cancer and the growing breast cancer diagnosis rate in developing countries.Based on guidance, the Breast Biopsy Devices Market is segmented into image-guided biopsy and liquid biopsy.

The liquid biopsy segment is further divided into NGS-based, PCR-based, and Microarray-based biopsy.

Among these, the NGS-based biopsy segment is expected to register significant growth over the forecast period.Based on type, the Breast Biopsy Devices Market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy.

Global Breast Biopsy Devices Market is expected to grow considerably in the forecast period owing to increase in number of breast cancer patients along with growing demand for minimally invasive surgeries.

Furthermore, governments of emerging economies are actively initiating public awareness programs for diagnosing and treating breast cancers.

Nevertheless, the unexplored areas across the globe and increasing awareness about the disorder is offering lucrative opportunities to breast biopsy device industry.Request a Free Sample Copy of Breast Biopsy Device Market Report @ https://www.millioninsights.com/industry-reports/breast-biopsy-device-market/request-sample Breast biopsy devices market is categorized on the basis of product, technique, application, end user and geography.

On the basis of product, the market is divided into needle-based biopsy instruments, procedure trays, localization wires and others.

Needle based biopsy segment further comprises core-needle biopsy, fine-needle aspiration and vacuum-assisted core biopsy.

Fine-needle segment is expected to hold larger market share of breast biopsy device due to increasing need for minimally invasive surgeries.Based on technique, breast biopsy device industry is divided into MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy and others.

Global Breast Biopsy Market: By Product (Biopsy Needles, Biopsy Tables), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy), Guidance Technology (Ultrasound-Guided, CT-Guided Biopsy), End-Users (Hospitals, Labs) –Global Forecast Till 2023Increased cancer detection rates globally have contributed to a rise in biopsy procedures.

The report covers the COVID-19 analysis of the global breast biopsy market and provides a detailed summary of market segments, current trends, growth projections, and market challenges from 2018 to 2023 (forecast period) to identify potential business opportunities.Free Sample Copy of  With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288  A biopsy is a small operation performed to remove tissue from the area of concern within the body.

There are various types of biopsy procedures depending on the technique, such as fine needle aspiration biopsy (FNAB), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB) prescribed by the doctor based on the size, location, and other characteristics of the breast abnormality.

In addition, market limitations include the high cost of surgical procedures and the complications involved.

Conversely, the advent of technologically advanced and minimally invasive breast biopsy devices is expected to create lucrative opportunities in the untapped market.

Surgical biopsy is divided into incisional biopsy and excisional biopsy.Based on guidance technology, the global market for breast biopsy has been classified into CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and other image-guided breast biopsy (PET and thermography).Based on end-user, the global market for breast biopsy has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and others.

Market GrowthA biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body.

The global breast biopsy market is expected to expand in significant fashion during the forecast period of 2018 to 2023.Latest Free Sample PDF Available @ https://www.marketresearchfuture.com/sample_request/6288The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast cancer screening programs are the major drivers of the market.

In addition to these, the market growth is also restricted due to the high cost of surgical procedures and the risks associated with them.

At the same time, the emergence of technologically-advanced and the usage of breast biopsy devices that are minimally invasive are expected to tap into the potential opportunities that the market holds.Market SegmentationThe global breast biopsy market statistics is segmented on the basis of type, application, and end user.On the basis of type, market is segmented into PET, mammography, CT, MRI, breast biopsy, tactile imaging, ultrasound, and others.

Breast biopsy is further segmented into ultrasound-guided core biopsy, image-guided breast biopsy, tactic core biopsy, and others.On the basis of application, the market is segmented into metastatic axillary adenocarcinoma, breast cancer diagnosis, post-neoadjuvant chemotherapy, and others.On the basis of end user, the market is segmented into diagnostic centers, hospitals, and others.Regional AnalysisThe regional analysis of the breast biopsy market observes that the North American region is projected to account for the principal market share owing to the early implementation of sophisticated medical technologies and constant development by companies working in cancer diagnostics.

The market share in the Asia Pacific region is also estimated to experience growth in the near future due to access to optimal treatment facilities, better adoption rate, growing demand for advanced technology, growing government initiatives, and rising healthcare costs.